Effects of mirtazapine on sleep disturbance under neuropathic pain-like state

Synapse

Volumn 66, Issue 6, 2012, Pages 483-488

  Enomoto, Tatsuya ^a,b   Yamashita, Akira ^b   Torigoe, Kazuhiro ^b   Horiuchi, Hiroshi ^b   Hirayama, Shigeto ^b,c   Nakahara, Kae ^b   Yanase, Makoto ^b   Sakai, Hiroyasu ^b   Ikegami, Daigo ^b   Nagase, Hiroshi ^c   Suzuki, Tsutomu ^b   Iseki, Masako ^a   Inada, Eiichi ^a   Narita, Minoru ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Mirtazapine; Neuropathic pain; Sleep disturbance

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; HISTAMINE H1 RECEPTOR; MIRTAZAPINE; SEROTONIN 5 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; HYPERALGESIA; LATENT PERIOD; LIGHT DARK CYCLE; MALE; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCIATIC NERVE; SLEEP DISORDER; SLEEP QUALITY; STIMULUS; THERMAL STIMULATION; WAKEFULNESS; WITHDRAWAL REFLEX;

ANIMALS; DISEASE MODELS, ANIMAL; HISTAMINE H1 ANTAGONISTS; HYPERALGESIA; MALE; MIANSERIN; MICE; MICE, INBRED ICR; NEURALGIA; PAIN MEASUREMENT; RECEPTORS, HISTAMINE H1; SCIATIC NERVE; SLEEP DISORDERS; WAKEFULNESS;

EID: 84862781023     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21532     Document Type: Article

References (16)

1. Aapro M, Blower P. 2005. 5-Hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: Can we safely reduce the dose of administered agents? Cancer 104: 1-18.
2. Anttila SA, Leinonen EV. 2001. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7: 249-264.
3. Berendsen HH, Broekkamp CL, Pinder RM. 1998. Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats. Psychopharmacology (Berl) 135: 284-289.
4. Gorman JM. 1999. Mirtazapine: Clinical overview. J Clin Psychiatry 60 ( Suppl 17): 9-13; discussion46-18.
5. Grond S, Zech D, Diefenbach C, Bischoff A. 1994. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9: 372-382.
6. Imai S, Saeki M, Yanase M, Horiuchi H, Abe M, Narita M, Kuzumaki N, Suzuki T, Narita M. 2011. Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci 31: 15294-15299.
7. Kast RE. 2001. Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy. Support Care Cancer 9: 469-470.
8. Kast RE, Foley KF. 2007. Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. Eur J Cancer Care (Engl) 16: 351-354.
9. Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS. 2008. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 62: 75-83.
10. Lee K, Cho M, Miaskowski C, Dodd M. 2004. Impaired sleep and rhythms in persons with cancer. Sleep Med Rev 8: 199-212.
11. Morin CM, Gibson D, Wade J. 1998. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14: 311-314.
12. O'Brien EM, Waxenberg LB, Atchison JW, Gremillion HA, Staud RM, McCrae CS, Robinson ME. 2010. Negative mood mediates the effect of poor sleep on pain among chronic pain patients. Clin J Pain 26: 310-319.
13. Pilowsky I, Crettenden I, Townley M. 1985. Sleep disturbance in pain clinic patients. Pain 23: 27-33.
14. Szegedi A, Schwertfeger N. 2005. Mirtazapine: A review of its clinical efficacy and tolerability. Expert Opin Pharmacother 6: 631-641.
15. Widegren H, Korsgren M, Andersson M, Greiff L. 2007. Effects of TNFalpha on the human nasal mucosa in vivo. Respir Med 101: 1982-1987.
16. Zgierska A, Brown RT, Zuelsdorff M, Brown D, Zhang Z, Fleming MF. 2007. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: A cross-sectional study. J Opioid Manag 3: 317-327.